Loading...

Use of anti-TNF drug levels to optimise patient management

Anti-tumour necrosis factor (TNF) therapies, such as infliximab, adalimumab, certolizumab pegol and golimumab, have been proven to be effective for the treatment of patients with Crohn's disease and ulcerative colitis. However, 10%–30% of patients with inflammatory bowel disease (IBD) show no i...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Frontline Gastroenterol
Main Authors: Papamichael, Konstantinos, Cheifetz, Adam S
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369499/
https://ncbi.nlm.nih.gov/pubmed/28839870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2016-100685
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!